Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

McLaren valued at over £3bn as majority owners eye full control

(Sharecast News) - McLaren Racing's majority shareholders are set to purchase the remaining 30% stake they don't already own in a deal that values the Formula One team at over £3bn, according to Sky News. Mumtalakat, the sovereign wealth fund of Bahrain, and auto investor CYVN are looking to buy out McLaren's remaining investors, including those that helped to inject much-needed capital in 2020.

According to Sky, Mumtalakat and CYVN are looking to purchase the stakes held by a number of smaller shareholders, including MSP Sports Capital, Ares Investment Management and UBS O'Connor.

US-based sports investment group MSP purchased a "significant minority shareholding" in McLaren back in 2020 in a deal that valued the company at £560m at the time.

The company is now said to be in a stronger financial position after the sale of its Applied Technologies unit and its headquarters in Surrey.

A deal between the two Gulf investors and remaining shareholders could be announced as early as Tuesday this week, Sky said.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.